H1 Hip Resurfacing vs Total Hip Replacement in Hip Arthritis
Official title: The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
Run by Embody Orthopaedic Limited · NCT06162195 · Data updated 2026-11-12
A randomized trial tests whether a new H1 hip resurfacing can match or beat a cementless ceramic total hip replacement for people with hip arthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Embody Orthopaedic Limited Industry-sponsored |
| Locations | 3 sites (Bournemouth and 2 other locations) |
| Status | Recruiting |
| Started | July 21, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2036 |
| Registry record updated | August 13, 2026 |
| Trial ID | NCT06162195 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with unilateral primary hip arthritis (osteoarthritis or inflammatory arthritis) who are candidates for hip arthroplasty and willing to participate long-term (up to 10 years).
✕Probably not a fit
Patients with very high BMI, active infection, poor bone stock, or other contraindications may not benefit and could be at higher risk.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial compares two hip replacement options for adults with hip arthritis: the H1 ceramic resurfacing implant versus a cementless ceramic-on-poly or ceramic-on-ceramic total hip replacement. Participants are assigned to one of the two procedures and followed over time to compare composite clinical success, physical activity, and patient-reported outcomes. The primary aim is to determine non-inferiority of the H1 implant for overall clinical success, with secondary goals evaluating activity levels, PROMs, safety, and patient-reported noise. Secondary analyses will also examine device- and surgery-related adverse events and other outcomes over up to 10 years of follow-up. The study enforces specific inclusion and exclusion criteria to select adults requiring unilateral primary hip arthroplasty and capable of long-term participation.
Why it matters
Potential benefit: If successful, participants and future patients may have a resurfacing option that preserves more bone and provides equal or improved function and activity levels.
How similar studies have gone: Previous resurfacing vs traditional total hip comparisons have shown mixed results; this trial tests non-inferiority in a contemporary cementless ceramic context which is less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient requires unilateral primary hip arthroplasty due to primary osteoarthritis, osteoarthritis secondary to e.g. trauma, avascular necrosis or developmental hip dysplasia, or inflammatory arthritis. * Patient is willing to comply with study requirements. * Patient plans to be available through 10 years postoperative follow-up. Exclusion Criteria: * Patient has a BMI greater than 40 kg/m². * Patient has active infection or sepsis (treated or untreated). * Patient has insufficient bone stock at the hip (\>1/3 necrosis of the femoral head or large and multiple cysts) or in general as in severe osteopenia or osteoporosis (t-score \< -2.5 as measured with BMD). * Patient is not skeletally mature. * Patient meets the contraindication criteria of the control device. * Patient already has another lower limb arthroplasty or arthrodesis or will require a further lower limb arthroplasty or arthrodesis within the subsequent 2 years. * Patient lacks capacity to consent. * Patient is unable to understand the native language of the country where their procedure is taking place
Where it's running
-
University Hospitals Dorset NHS Foundation Trust
Bournemouth, United Kingdom Recruiting -
University Hospitals Coventry & Warwickshire
Coventry, United Kingdom Recruiting -
Royal Cornwall Hospitals NHS Trust
Truro, United Kingdom Recruiting
Study contacts
- Principal investigator: Justin Cobb, Prof — Imperial College London
- Study coordinator: Camilla Halewood, PhD
- Email: camilla.halewood@embody-ortho.com
- Phone: +442035764981
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collarless Actis hip stem for cementless hip replacement in Asian patients
This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.
-
Intravenous dexamethasone for better pain control after hip replacement with a PENG block
This study tests whether giving dexamethasone through a vein, in 0, 4, or 8 mg doses, helps control pain after total hip arthroplasty when used with a PENG block.
-
Long-term follow-up of FX Shoulder Solutions implants
This follow-up will track adults who receive FX Shoulder Solutions hemi or total shoulder replacements to see if the implants need revision and how well shoulder function and pain hold up over 10 years.
-
Palliative and supportive care to help people with inflammatory arthritis live well
This project will see how palliative and supportive care could help adults with inflammatory arthritis live better throughout their illness.
-
Comparing barbed and conventional wound closure after hip or knee replacement
This study will test whether barbed sutures or conventional sutures lead to better wound healing and fewer complications for adults having primary or aseptic revision hip or knee replacement.
-
HbA1c accuracy in people with inflammatory arthritis on sulfasalazine
This study tests whether HbA1c reliably reflects blood glucose in adults with inflammatory arthritis who are treated with sulfasalazine, by comparing it to continuous glucose monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.